156 Views | 198 Downloads
Corresponding author: William.hu@emory.edu
Authors’ contributions: MM, JAT, WTH, MWP, and DQ were responsible for the conception and design of the study.
JCH, MWP, and WTH were responsible for the acquisition of the data.
MM, JAT, and WTH were responsible for analysis, and interpretation of data, drafting the manuscript and revising it critically for important intellectual content.
All authors read and approved the final manuscript.
Acknowledgements: The authors acknowledge the following persons for assistance with enrollment: James Lah, MD, PhD; Allan Levey, MD, PhD; Chadwick Hales, MD, PhD; Angela Ashley, MD; Felicia Goldstein, PhD; and Andrea Kippels, CNP.
Competing interests: WTH has a patent (assignee, Emory University) on the use of CSF p/t-Tau ratio in the evaluation of frontotemporal lobar degeneration, has received research support from Avid Pharmaceuticals, and has received travel support from Eli Lilly and Hoffman-La Roche.
DQ has received research support from Medtronic and Siemens Healthcare.
This work was supported by National Institutes of Health grants AG43885, AG42856, AG25688, and AG61660.
© 2020 The Author(s).